SOLACI Research Registries were presented at the SOLACI-SBHCI 2023 Congress

The area of records within SOLACI – SOLACI Research – continues to grow and share the results of its investigations with the entire Latin American interventional community.

In this case, a dedicated session was held during the SOLACI-SBHCI 2023 Congress to present the data from the SOLACI records and to discuss the challenges of carrying out reliable research initiatives that allow extracting valuable information to support therapeutic approaches that result in a better quality of life for patients in the region.

In the first presentation, Dr. Nicolás Zaderenko presented the results to date from the Latin American Coronary Bifurcation Registry, which already includes more than 1300 patients in 10 countries in Latin America.

Loading...

Next, Dr. Alexandre Schaan de Quadros (BRA) was invited to present the results of LATAM CTO, a registry that is not part of SOLACI Research but collects valuable data on chronic occlusions in our region.

Later on, Dr. Maximiliano Rossi (ARG) shared the results of the SOLACI Peripheral Registry and highlighted the value of this registry because it allows access to data from patients in the region for the first time. The registry, created in 2020, surveys the reality of patients with Lower Limb Angioplasty in the region and aims to understand their clinical and angiographic characteristics. In this regard, this initiative already includes more than 1200 patients enrolled in more than 9 Latin American countries.

Loading...

Continuing with the session, Dr. Henrique Ribeiro (BRA) presented the TAVI Guidelines developed in conjunction with the Inter-American Society of Cardiology (SIAC). In this regard, during the symposium, the importance of having the support of a clinical society regarding data reliability was emphasized.

Finally, Dr. Pablo Lamelas, Director of SOLACI Research, presented the brand new Left Main Revascularization Guidelines, also developed with SIAC.

Loading...

Towards the end of the session, Dr. Mangione, former President of SOLACI, congratulated the members of the SOLACI Peripheral Registry for all the work done and encouraged them to continue working to make these registries even larger.

If you wish to join the SOLACI Research records, please write to research@solaci.org.”


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

You can now rewatch the virtual event we held on April 9th, where we thoroughly reviewed the steps to apply for the SOLACI Research...

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

The Latin American Society of Interventional Cardiology invites you to a new virtual event hosted by the SOLACI Research Department, aimed at clarifying doubts,...

Watch our event on Evidence and Controversies of Renal Denervation in 2025

You can now watch our event, held in collaboration with Medtronic, titled "Evidence and Controversies of Renal Denervation in 2025." The event featured international experts...

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

The Latin American Society of Interventional Cardiology invites you to a new virtual event supported by Medtronic. On this occasion, we will hold a 60-minute...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACURATE Neo2 Underexpansion: Prevalence and Clinical Implications

While transcatheter aortic valve replacement (TAVR) provides durable clinical benefits across a wide range of patients, technical challenges remain that may affect long-term outcomes....

Spontaneous Left Main Dissection: Clinical Characteristics, management and Outcomes

Courtesy of Dr. Juan Manuel Pérez. Spontaneous left main dissection in an uncommon, and potentially life-threatening, cause of acute MI. The aim of this study,...

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...